# Botulinum Toxin Injection for the Management of BPH

> **NCT00451191** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 134 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** botulinum toxin type A (BoNT/A)

## Key facts

- **NCT ID:** NCT00451191
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00451191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00451191, "Botulinum Toxin Injection for the Management of BPH". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00451191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*